Thank you for your interest in viewing the Webinar Archive 8/17/10 webinar! Please join us on August 17, 2010 at 12:00 AM EDT
The goal of our webinars is to provide direct answers to people with ALS, their families and others involved or interested in research leading to the development of effective treatments and cures for ALS.
This session will review the three Phase 3 trials enrolling people with ALS in the US/EU right now: NurOwn, levosimendan, and arimoclomol as well as major Phase 2 trials, such as reldesemtiv.
Visit us in Watertown, MA
Can't Make it to the Lab?
We would still love to share our lab with you. Learn more about our machines, space, and research online.